Lung cancer biomarker study in Malaysia
Part of Cancer, Lungs & breathing clinical trials.
This study looks for early signs of lung cancer in people at higher risk. It tests blood and imaging to find markers that might help detect lung cancer sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 30 years or older.
- You have never had any type of cancer.
- You have a chest X-ray or low-dose CT scan result available.
- You have COPD or a lung nodule smaller than 11mm, or a nodule your doctor said does not need a biopsy.
- You are willing to come back for a follow-up scan as part of your regular care.
- You are willing to give blood samples: about 2 tablespoons at your first visit and about 1.5 tablespoons at a follow-up visit.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether combining low-dose chest CT scans with blood “biomarker” tests can help find lung cancer earlier in people at higher risk. You may be asked to have scans and blood tests and then attend follow-up visits over time.
This study uses a blood test to look for tiny genetic markers (miRNA and DNA methylation) that may help detect lung cancer early. If you have a lung nodule or mass found on a CT scan and haven't had treatment yet, you may be able to join.
This study looks at whether a new test can better identify early lung cancer in people who are being watched for an incidental lung nodule. It may help doctors decide which nodules need closer follow-up or treatment.
This study looks at whether combining lung images with a blood test (DNA methylation) can help find lung cancer early. It is for people who have a new diagnosis of lung cancer and have not had treatment yet, as well as for people without cancer as a comparison.
This study collects blood, tissue, and other samples from people with lung nodules, suspected lung cancer, or confirmed lung cancer to find better ways to diagnose and treat the disease. By joining, you help researchers discover new biomarkers that could improve care for future patients.
This study is for people at high risk of lung cancer—either long-term heavy smokers or those with a close family member who had lung cancer. It uses a low-dose CT scan to look for early signs of lung cancer, and if you smoke, you'll be asked to join a smoking cessation program.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.